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Abstract
Background: Macrocytic anaemia (MCV ≥ 100 fL) is a relatively common finding in general practice. However,
literature on the prevalence of the different causes in this population is limited. The prevalence of macrocytic
anaemia and its underlying aetiology were analysed in a general practice population. The potential effect of the
different aetiology on survival was also evaluated.
Methods: Between the 1st of February 2007 and the 1st of February 2015, patients aged 50 years or older and
presenting to their general practitioner with a newly diagnosed anaemia, were included in the study. Anaemia was
defined as haemoglobin level below 13.7 g/dL in men and below 12.1 g/dL in women. A broad range of laboratory
tests was performed for each patient. The causes of anaemia were consequently determined by two independent
observers based on the laboratory results.
Results: Of the 3324 included patients, 249 (7.5 %) displayed a macrocytic anaemia and were subsequently analysed.
An underlying explanation could be established in 204 patients (81.9 %) with 27 patients (13.2 %) displaying multiple
causes. Classic aetiology (i.e. alcohol abuse, vitamin B12/folic acid deficiency, haemolysis and possible bone marrow
disease) was found in 115 patients. Alternative causes (i.e. anaemia of chronic disease, iron deficiency, renal anaemia
and other causes) were encountered in 101 patients. In addition, a notable finding was the median gamma GT of 277
U/L in patients diagnosed with alcohol abuse (N = 24, IQR 118.0-925.5) and 23 U/L in the remaining cohort (N = 138,
IQR 14.0-61.0). The distribution of gamma GT values was statistically different (P < 0.001).
Five year survival rates were determined for six categories of causes, ranging from 39.9 % (95 % CI 12.9-66.9) for renal
anaemia to 76.2 % (95 % CI 49.4-103.0) for the category multiple causes.
Conclusion: In addition to classic explanations for macrocytosis, alternative causes are frequently encountered in
patients with macrocytic anaemia in general practice.
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Background
Anaemia is regularly encountered in general practice
and hospital settings. In a community dwelling popula-
tion, the prevalence of anaemia starts increasing after
age 50, starting from about 5.5 % in the age group 50-64
years and rising to over 20 % in the age group 85 and
older [1]. Anaemia has been shown to be an independ-
ent predictor of survival in a population of community-
dwelling older adults and is capable of negatively influ-
encing quality of life [2, 3].
Macrocytic anaemia (mean corpuscular volume
(MCV) ≥ 100 fL) is a relatively common finding.
Prevalence estimates for macrocytosis range from
1.7 % to 3.9 % [4, 5]. About 40 % of patients present-
ing with macrocytosis display an associated anaemia
[4, 5]. Classic causes of macrocytosis include nutrient
deficiencies (i.e. vitamin B12 and folic acid), alcohol
abuse, liver disease, haemolysis, medication and pri-
mary bone marrow disease (e.g. myelodysplastic syn-
drome (MDS)) [3–6]. Alternative causes include iron
deficiency anaemia (IDA), anaemia of chronic disease
(ACD) and renal anaemia, with prevalence ranges of
13.6-47.2 % [7], 16.0-19.0 % [8–10] and 10.5-19.7 %
[9–12], respectively. However, the prevalence of these
causes in patients with macrocytic anaemia remains
to be determined.
A cohort study was set up to systematically evaluate
patients presenting with anaemia to their general practi-
tioner. Since literature on macrocytic anaemia in general
practice is limited, this study cohort was used to clarify
the prevalence of macrocytic anaemia and its aetiology
in newly diagnosed anaemia patients in general practice.
Besides considering the classical causes of macrocytosis,
the prevalence of laboratory abnormalities associated
with IDA, ACD and renal anaemia was evaluated, since
these have not been described in a macrocytic cohort be-
fore. The potential impact of the different aetiology on
survival was also assessed.
Methods
Patient inclusion
This study was approved by the ethical committee of the
Albert Schweitzer Hospital and was part of a large trans-
mural project aimed at anaemic general practice patients
aged 50 years and older. The main goal of this project is
to improve care provided for anaemic patients. The
study was conducted in the Western part of the
Netherlands, and included 63 participating general prac-
titioners. Patients presented to a general practitioner
(GP) displaying symptoms indicative of anaemia (e.g. fa-
tigue, dizziness, pallor or general malaise). If laboratory
tests established a newly diagnosed anaemia (i.e. no
known anaemia the preceding two years), a standardised
laboratory work-up was immediately performed. Anaemia
was defined as haemoglobin level below 13.7 g/dL
(8.5 mmol/L) for men and below 12.1 g/dL (7.5 mmol/L)
for women. These levels constitute the cut-off values
recommended by the Dutch College of General Practi-
tioners (DCGP) [13]. Patients were included between
the 1st of February 2007 and the 1st of February 2015.
The follow-up period ended on the 1st of March 2016.
From this anaemic cohort, all patients with a macrocytic
anaemia (MCV ≥ 100 fL) were selected for further
analysis.
Laboratory work-up and data collection
For each patient, a standardised laboratory work-up was
performed, including haemoglobin, MCV, erythrocytes,
erythrocyte sedimentation rate, reticulocytes, thrombo-
cytes, leukocytes, ferritin, transferrin, serum iron, serum
vitamin B12, serum folic acid, gamma GT, lactate de-
hydrogenase (LDH), creatinine and C-reactive protein
(CRP). This work-up allowed for the consideration of a
broad range of causes of anaemia. The results for
gamma GT and creatinine were not complete for all pa-
tients. Due to retrospective data collection, these values
could not be recovered. At the discretion of the general
practitioner, patients were referred to the hospital for
additional diagnostic testing. For these patients, a hos-
pital chart review was conducted and any additional ex-
aminations were analysed.
Classification of causes of macrocytic anaemia
A classification system was developed, which included
the following causes: 1) vitamin B12 deficiency 2) folic
acid deficiency 3) possible bone marrow disease 4)
haemolysis 5) documented alcohol abuse 6) anaemia of
chronic disease (ACD) 7) iron deficiency anaemia (IDA)
8) renal anaemia and 9) other. If no cause could be de-
termined, it was classified as unknown. See Table 1 for
the definition of each cause.
Regularly, patients diagnosed with renal anaemia also
displayed features of ACD. These features were consid-
ered due to the present renal anaemia, and therefore,
ACD was not classified as a separate cause in these
cases. The cause of anaemia was established by two in-
dependent observers (authors KS and ML, anaemia re-
searcher and haematologist, respectively). In case of
discordance, the observers deliberated until a consensus
was reached. Patients with missing creatinine values
could not be considered for the cause renal anaemia.
The possible association of the patient’s age group (50-
64 years, 65-74 years, 75-84 years and 85+ years) and
gender with the diagnosed cause of macrocytic anaemia
was also analysed. Vitamin B12 deficiency, folic acid de-
ficiency and iron deficiency were combined into the
cause ‘nutrient deficiency’ for analysis.
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Factors influencing survival
Survival data was extracted from the hospital and la-
boratory information system. Patients were followed
until either their deaths, or until the 1st of March 2016,
at which moment they were censored at the last date
they were documented as alive in the hospital or labora-
tory information system.
Patients were classified into six groups for survival
analysis; nutrient deficiency (vitamin B12 deficiency,
folic acid deficiency and iron deficiency), ACD, renal an-
aemia, multiple causes (patients who presented with a
double or triple cause, except those presenting with only
nutrient deficiencies), other (haemolysis, possible bone
marrow disease, documented alcohol abuse and other)
and unknown.
Statistics
Continuous variables were described using medians
and interquartile ranges (IQR), and categorical vari-
ables were described using percentages. Fisher’s exact
tests were used to compare the relative prevalence
(among all patients with macrocytic anaemia) of
causes of anaemia between men and women and be-
tween different age groups. This test was chosen to
account for the very small number of cases in some
comparisons. These tests were performed separately
for each cause of anaemia (vitamin B12, folic acid
and iron deficiency combined into nutrient deficiency)
and for each pair of age groups. The Mann-Whitney
test was used to compare the distribution of gamma
GT values between patient groups. Kaplan-Meier ana-
lysis and the log rank test were used for a univariate
analysis of the association between causes of anaemia
and survival. A Cox proportional-hazards model cor-
recting for the cause of anaemia, age (coded as a con-
tinuous variable), gender, date of inclusion, and
haemoglobin (divided into mild (Hb ≥ 10.0 g/dL),
moderate (Hb 8.0-9.9 g/dL) and severe (Hb < 8.0 g/
dL) anaemia) level was used for a multivariate ana-
lysis of survival. The proportional hazards assumption
in this model was tested by including interaction
effects of the independent variables with time in a
Cox model with time-dependent covariates. To ac-
count for the effects of multiple testing, a Bonferroni-
adjusted significance level of 0.006 was used for Fish-
er’s exact tests and a level of 0.008 was used for log-
rank tests. For all other tests, a two-sided significance
level of 0.05 was used. Calculations were performed
using Statistical Package for Social Sciences (SPSS)
version 18 for Windows.
Results
Over the span of eight years, a total of 3324 patients
with newly diagnosed anaemia were included in the
study, of whom 249 (7.5 %) patients presented with a
macrocytic anaemia; 140 men (median age 75 years,
IQR = 63-82 years) and 109 women (median age 80 years,
IQR = 72.5-87 years). An overview of the patient charac-
teristics can be found in Table 2.
A single cause of anaemia was established in 177 pa-
tients (71.1 %). A double cause was established in 26 pa-
tients (10.4 %) and a triple cause in one patient (0.4 %).
A total number of 232 causes could be established in
these 204 patients, while the cause remained unknown
in 45 patients (18.1 %).
Classic causes
In this cohort, 115 patients (46.2 %) presented with a
total of 129 classic causes of macrocytic anaemia.
Vitamin B12 deficiency was found 46 times and folic
acid deficiency 16 times. Documented alcohol abuse
was established 31 times, haemolysis 9 times and pos-
sible bone marrow disease 27 times (Fig. 1). Bone
marrow examinations performed in this last category
revealed seven cases of myelodysplastic syndrome
(MDS), six cases of acute myeloid leukaemia, two
cases of chronic lymphoid leukaemia and two cases of
multiple myeloma. In one patient no pathology could
be found. In six patients with possible bone marrow
disease, no further examinations were performed due
to their advanced age, while in the remaining three
patients, the abnormal leukocytes and thrombocytes
Table 1 Definitions of the different causes found in the
macrocytic cohort
Cause Definition
1) Vitamin B12 deficiency Vitamin B12 < 130 pmol/L
2) Folic acid deficiency Folic acid < 5 nmol/L
3) Possible bone marrow
disease
Abnormal number leukocytes and
thrombocytes
Reticulocytes < 2.5 %




Documented in patient file by treating
physician
6) Anaemia of chronic
disease (ACD)
Ferritin > 100 μg/L, serum transferrin
< 2.0 g/L and/or serum iron < 14 μmol/L
(men), < 10 μmol/L (women)
7) Iron deficiency anaemia
(IDA)
Ferritin < 25 μg/L (men), < 20 μg/L
(women)
8) Renal anaemia Estimated creatinine clearance (MDRD)
≤ 45 mL/min/1.73 m2 (8)
9) Other Documented in patient file by treating
physician
10) Unknown No cause could be determined
These cut-off values were derived from the reference intervals used in the
Clinical Chemistry laboratory of the Albert Schweitzer Hospital where all tests
were conducted
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counts were deemed related to the concurrent nutri-
ent deficiency.
Alternative causes
A total of 103 alternative causes of macrocytic anaemia
were found in 101 patients (40.6 %). IDA was encoun-
tered 4 times and ACD was found 55 times. Renal an-
aemia was established 36 times and other causes 8 times
(Fig. 1). This last category included three patients pre-
senting with gastrointestinal bleeding, and three patients
diagnosed with hypothyroidism. One patient was diag-
nosed with liver cirrhosis and one patient presented
shortly after undergoing surgery.
Unknown cause of anaemia
Forty-five patients presented with an unknown cause for
their anaemia. Two patients underwent a bone marrow
examination in an attempt to elucidate the underlying
aetiology. One patient was subsequently diagnosed with
MDS. For the second patient, the cause of anaemia
remained unknown.
Factors influencing diagnosis
Age 58, 40, 85 and 66 patients were found in the age
groups 50-64 years, 65-74 years, 75-84 years and 85+
years, respectively.
Documented alcohol abuse (Fig. 2-a) was most often
found in the age group 50-64 years (24 of the 31 cases
(77.4 %)). Significant differences were found between
this age group and the other three groups (P < 0.001 for
all comparisons). Increased gamma GT is often associ-
ated with alcohol abuse. The median gamma GT value
of patients diagnosed with alcohol abuse was 277.0 U/L
(N = 24, IQR 118.0-925.5). The remaining cohort showed
a median value of 23.0 U/L (N = 138, IQR 14.0-61.0).
The distribution of gamma GT values between these two
groups was statistically different (P < 0.001).
Renal anaemia (Fig. 2-b) showed a rising prevalence
per age group from 1 case in 50-64 years (1.7 %) to 19
cases in 85+ years (28.8 %). For this cause, a significant
difference was found between age groups 50-64 years
and 85+ years (P < 0.001).
Gender Renal anaemia was diagnosed more often in
women compared to men, in 22 of 109 (20.2 %) and 14
of 140 (10.0 %) patients, respectively, but this difference
was not significant (P = 0.019). No other distinct obser-
vations were made when analysing the association of
gender with the cause of anaemia.
Factors influencing survival
The median follow-up period lasted 29 months (95 % CI
25-32 months, IQR 14-52). The Kaplan-Meier estimate
of five-year survival rate from the moment of inclusion
was 58.8 % (95 % CI 50.4-67.2) for the overall popula-
tion, with a rate of 58.7 % (95 % CI 48.1-69.3) for men
and a rate of 58.4 % (95 % CI 44.2-72.6) for women.
Five-year survival rates were also determined for the six
groups used for survival analysis: nutrient deficiency
51.9 % (95 % CI 31.7-72.1), anaemia of chronic disease
59.2 % (95 % CI 42.0-76.4), renal anaemia 39.9 % (95 %
CI 12.9-66.9), other causes 61.4 % (95 % CI 47.2-75.6),
multiple causes 76.2 % (95 % CI 49.4-103.0) and un-
known 68.8 % (95 % CI 47.6-90.0) (See Fig. 3). The log
rank test revealed no significant differences in survival
between these groups (P = 0.192).
The possible association of the six main causes with
survival after entry into the study was analysed using a
Cox proportional hazards model, correcting for age, gen-
der, date of inclusion and haemoglobin level. The group
‘unknown’ was selected as reference since its median
haemoglobin level was closest to the normal range (per-
sonal observation by author) and due to its size. How-
ever, no significant association of anaemia aetiology with
survival was found (See Table 3). No significant viola-
tions of the proportional hazards assumption were
detected.
Table 2 Patient characteristics of 249 patients with macrocytic
anaemia
Parameters Median: IQR Reference values
Age 78.0 years: 65.0-85.0
- Men 75.0 years: 63.0-82.0
- Women 80.0 years: 72.5-87.0
Haemoglobin 11.8 g/dL: 10.5-12.9
- Men 12.9 g/dL: 11.3-13.2 13.7-17.7 g/dL
- Women 11.3 g/dL: 10.2-11.8 12.1-16.1 g/dL
MCV 103 fL: 101-108
Erythrocytes 3.5 10^12/L: 3.0-3.8
- Men 3.8 10^12/L: 3.1-4.0 4.6-6.2 10^12/L
- Women 3.3 10^12/L: 2.9-3.6 4.2-5.4 10^12/L
Reticulocytes 1.3 %: 0.9-1.8 <2.5 %
Thrombocytes 218.0 10^9/L: 166.0-272.5 150-400 10^9/L
Leukocytes 6.7 10^9/L: 5.0-8.7 4.3-10.0 10^9/L
Ferritin 225.0 μg/L: 131.5-464.0
- Men 250.5 μg/L: 137.0-557.8 25-250 μg/L
- Women 197.0 μg/L: 107.0-385.0 20-150 μg/L
Creatinine* 84.0 μmol/L: 70.0-105.5
- Men 88.0 μmol/L: 72.5-105.0 59-104 μmol/L
- Women 76.5 μmol/L: 62.0-106.0 45-84 μmol/L
Gamma GT* 27.5 U/L: 16.0-112.5
- Men 29.5 U/L: 18.0-168.5 <50 U/L
- Women 23.0 U/L: 14.0-95.0 <35 U/L
The interquartile range (IQR) is denoted by the first and third quartile. *The
number of patients with values for creatinine and gamma GT were 209 and
162 patients, respectively
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Fig. 1 An overview of the frequency of each established cause in a macrocytic population. For each patient the cause or causes were diagnosed
by two independent observers
Fig. 2 Number of cases per age group for the causes documented alcohol abuse (a) and renal anaemia (b)
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Discussion
To determine the prevalence of macrocytic anaemia and
its causes, defined as associations with laboratory abnor-
malities, the macrocytic patients of a unique cohort of
patients presenting to their general practitioner with
newly diagnosed anaemia, were analysed. Both classic
and alternative causes of macrocytic anaemia were regu-
larly established in this cohort. To the best of our know-
ledge, this is the largest study of macrocytic anaemia
patients in general practice to date.
Several algorithms have been developed to aid in diag-
nosing the underlying cause of macrocytic anaemia [3,
14–16]. ACD, IDA and renal anaemia are rarely consid-
ered causes of macrocytic anaemia by these algorithms,
since these causes are usually reported in patients with a
microcytic (MCV ≤ 80 fL) or normocytic (80 <MCV >
100) anaemia [15, 17, 18]. However, all three causes were
frequently encountered in this macrocytic population. It
is unclear what causes this shift towards macrocytosis in
these patients. In literature, Andrews (2008) mentioned
a possible tendency of the erythrocytes in ACD towards
macrocytosis, but did not explain this further [19]. Fur-
thermore, patients with IDA, ACD and renal anaemia
were, on average, only mildly macrocytic compared to
patients diagnosed with classical causes of macrocytosis,
such as nutrient deficiency, alcohol abuse and possible
bone marrow disease (personal observation by author).
Fig. 3 Kaplan-Meier curves of the survival from the moment of inclusion for the six main causes included in survival analysis. The log-rank test
showed no significant differences in survival between causes (P = 0.192)
Table 3 Results of Cox proportional-hazards model
Hazard ratio 95 % CI P-value
Cause 0.213
Nutrient deficiency 1.84 0.76-4.48 0.179
Anaemia of chronic disease 2.47 1.05-5.82 0.038
Renal anaemia 2.31 0.93-5.74 0.072
Other causes 2.94 1.27-6.82 0.012
Multiple causes 2.09 0.54-8.07 0.285
Unknown Reference
Severity (haemoglobin) 0.476
Moderate 1.41 0.64-3.12 0.396
Severe 0.62 0.19-2.04 0.433
Mild Reference
Gender 0.287
Female 0.77 0.47-1.25 0.287
Male Reference
Age (years) 1.06 1.03-1.09 <0.001
Date of inclusion (years) 0.927 0.82-1.04 0.213
The Cox proportional-hazards model analysing the possible association of the
aetiology of macrocytic anaemia with survival after entry into the study, found
no significant results for the different causes
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For the purpose of this study, a strict limit was
used when establishing the presence of vitamin B12
or folic acid deficiency. However, values measured
just above these limits (range 131-200 pmol/L for
vitamin B12 and 5-10 nmol/L for folic acid) may not
necessarily exclude a deficiency. Several patients who
were classified as having an ACD, IDA or renal an-
aemia, may have had an additional underlying defi-
ciency of vitamin B12 or folic acid, which remained
unclassified due to these strict limits. Other possible
explanations for the presence of ACD, IDA and renal
anaemia cases, include an undiscovered underlying al-
cohol abuse or undetected bone marrow disease.
Certain medications can also cause macrocytosis.
However, a complete record of medication was not
available for each patient.
According to Younes et al. (2013), unexplained macro-
cytosis may be a prelude to a bone marrow disease;
11.6 % of their patients developed a bone marrow dis-
ease during the study period [5]. However, at the end of
the follow-up period, only 1 of the 45 patients (2.2 %)
presenting with unknown anaemia in this study was di-
agnosed with such disease, according to the documenta-
tion available in the hospital information system. The
strict limits used for the classification of vitamin B12
and folic acid deficiency or undetected alcohol abuse, as
described above, may also explain the presence of mac-
rocytic anaemia in the 44 patients whose cause of an-
aemia remained unknown (the 45th patient with
unknown anaemia was subsequently diagnosed with
MDS). The MDRD value was unknown in nine patients
in this category, leaving us unable to exclude the pres-
ence of renal anaemia.
Documented alcohol abuse was found most often
among those aged 50-64 years. After age 65, the
prevalence began to decrease. This is consistent with
data from a large-scale study aimed at determining
prevalence of alcohol abuse performed in the United
States [20].
Renal anaemia showed a prevalence rising with age
and was found significantly more often in patients older
than 75 years. This may be explained by a decrease in
renal function with age [21]. In addition, renal anaemia
was observed more often among women. This may be
due to the relatively high proportion of women in the
two oldest age groups; 68.7 % of the included women
were over 75 years old at the time of inclusion versus
45.0 % of men.
The possible association of different causes of anaemia
with survival has not been studied before within a mac-
rocytic cohort. However, no significant influence of the
causes nutrient deficiency, renal anaemia, anaemia of
chronic disease, other causes and multiple causes on
survival could be found.
Limitations
Due to the retrospective set-up of the study, it relied
completely on patient records. Laboratory records were
complete but records kept by the GP were inaccessible
while hospital records were not available for each pa-
tient, resulting in an incomplete overview of medication,
co-morbidity, alcohol abuse and follow-up diagnostics.
Due to loss of follow-up the survival data were not
complete for each patient. At-risk patients are more
likely to visit the hospital or laboratory and therefore
more likely to have complete survival data. This may
have lowered the calculated survival rate. The median
age of this population is high (78 years), which may
make age too strong a confounding factor for this sur-
vival analysis.
Conclusions
Macrocytic anaemia was found in 7.5 % of patients with
a newly diagnosed anaemia in general practice. Notable
findings were the high prevalence of alcohol abuse in the
age group 50-64 years and the often multifactorial na-
ture of anaemia in this elderly population (≥50 years).
Laboratory abnormalities associated with anaemia of
chronic disease, iron deficiency anaemia and renal an-
aemia were frequently encountered in this macrocytic
cohort. However, current algorithms for the diagnosis of
macrocytic anaemia generally do not consider these al-
ternative causes. The different underlying causes of
anaemia could have severe consequences should they re-
main undetected. A broad diagnostic work-up, without
being led by the MCV, is therefore recommended to
fully elucidate the underlying cause of macrocytic
anaemia.
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